People's Livelihood and Drug Safety

Abstract

Abstract: Medicine is an important tool for protecting public health.So the drug safety is always concerned with a matter of the people's livelihood. As an essential content of the basic health system, drug safety protecting is one of the primary subjects in improving people's livelihood. This article analyzes the definition of people's livelihood and drug safety, discusses the relationship between them and provides some advice and reference on drug safety administration.

Key words: people's livelihood, drug safety, definition, relationship

LIU Jia, LI Guo-qing. People's Livelihood and Drug Safety[J]. Chinese Journal of Pharmacovigilance, 2012, 9(6): 338-339.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2012/V9/I6/338

[1]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[2]	NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan. Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
[3]	CHEN Yingren, XUE Zeyu, HUANG Tianchi, LIANG Yihong, LIN Ziqi, XIU Linlin. Toxicity/Efficacy Relationship of Sargassum and Glycyrrhizae Radix et Rhizoma: a Visual Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 93-98.
[4]	LU Zhenkai, YANG Dingquan, XIE Zhennian, WANG Lianxin, LI Yuanyuan, WANG Zhifei, CUI Xin, XIE Yanming. Interpretation and insights from the “Guidelines for Pharmacovigilance of Topical Traditional Chinese Medicines in Clinical Applications” [J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1029-1033.
[5]	SHI Guanhong, WANG Qi, SUN Hao, CHEN Yanjie, CHU Ziyan, JIANG Ao, TANG Zaixiang, LIU Jingfang. Safety signal analysis of antidepressants use in fetus and neonate based on US FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 687-692.
[6]	WANG Chunnan, QIN Shiru, ZHANG Meng, SONG Haibo, LIU Junchang, LI Ge, SUN Feng. Evaluation of drug safety with multicenter real-world data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 703-708.
[7]	CAO Ying, ZHOU Huziwei, ZHU Lan, WANG Shengfeng. Management of compound glycyrrhiza oral solution and recommendations [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 529-534.
[8]	SU Xiaohan, ZENG Jiao, LI Xue, LIU Lixin, HOU Lingmi, LI Jinsui. Adverse events of abemaciclib in breast cancer patients based on US FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 580-586.
[9]	MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin. Drug traceability coding system in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172.
[10]	SONG Fuyu, CAO Yi. Establishment of Key Performance Indicators for Drug Inspection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1411-1414.
[11]	WANG Xiang, SUN Shuai, WANG Xinguo, NIU Liying. Quantitative transfer relationships of Rubia yunnanensis Diels formula granules based on standard decoctions [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 891-898.
[12]	LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng. Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628.
[13]	LIANG Shibing, YU Zeyu, KONG Lingyao, YAN Lijiao, HAN Mei, WU Jiarui, LIU Zhaolan, LIU Jianping. Applicability of bibliometric methods pharmacovigilance of traditioual Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 591-594.
[14]	LIN Ni, YE Qian, GENG Xingchao, WANG Xue, JIN Hongtao, WEN Hairuo. Genotoxicity of 5-hydroxymethylfurfural and its dipolymer and metabolite [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 157-162.
[15]	JIANG Jiandong. Development and clinical safety of paediatric medicines in China [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 1-6.

People's Livelihood and Drug Safety

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics